Oncology & Cancer
EU approves treatment for prostate cancer
The European Union has approved a new treatment against an advanced type of prostate cancer by Novartis, the Swiss pharmaceutical giant said Tuesday.
Dec 13, 2022
0
4
News tagged with novartis
Medications
Swiss drugmaker Novartis to spin off generics unit Sandoz
Swiss pharmaceuticals company Novartis said Thursday that it plans to spin off its generics subsidiary Sandoz, which generated nearly $10 billion in revenue last year.
Aug 25, 2022
0
17
Medications
Novartis says two children treated with gene therapy died
Two children who received Zolgensma, a gene therapy produced by Swiss drugmaker Novartis to treat spinal muscular atrophy, have died from liver failure, the company said Friday.
Aug 12, 2022
0
13
Other
Novartis to acquire UK-based ocular gene therapy company
Swiss pharmaceutical giant Novartis said Wednesday it was to acquire a UK-based biotech company developing gene therapies for eye diseases called Gyroscope Therapeutics.
Dec 22, 2021
0
2
Vaccination
Novartis signs new deal to help produce Pfizer/BioNTech vaccine
Swiss pharmaceuticals giant Novartis said Thursday it has signed a new agreement to farm out some of its production facilities and help manufacture much-needed doses of the Pfizer-BioNTech coronavirus vaccine.
Oct 21, 2021
0
6
Medications
Novartis, Roche team up on COVID pneumonia drug
Novartis announced Thursday it will join forces with fellow Swiss pharmaceutical giant Roche to produce tocilizumab, a drug being tested for its effectiveness against COVID-19-linked pneumonia.
Apr 15, 2021
0
3
Medications
EU approves Novartis's advanced breast cancer drug
EU regulators have approved Novartis's new Piqray drug to treat advanced breast cancer, the Swiss pharma giant said Wednesday.
Jul 29, 2020
0
5
Medications
Novartis to pay $336 mn in US settlements on bribes
Novartis agreed to pay around $336 million to settle US charges connected to bribery schemes aimed at increasing sales of its pharmaceutical products, US authorities announced Thursday.
Jun 25, 2020
0
5
Medical research
Novartis holds off on drug price hikes in US amid Trump pressure
Swiss pharmaceutical giant Novartis said Wednesday it would not hike drug prices in the United States this year, following a similar decision by rival Pfizer amid pressure from the White House.
Jul 18, 2018
0
0
Oncology & Cancer
FDA approves CAR T therapy for large B-cell lymphoma
The U.S. Food and Drug Administration (FDA) has expanded approval for a personalized cellular therapy developed at the University of Pennsylvania's Abramson Cancer Center, this time for the treatment of adult patients with ...
May 1, 2018
0
128
Novartis
Novartis International AG is a multinational pharmaceutical company based in Basel, Switzerland, ranking number one in revenues, which accounted over $53 billion in 2008, and number three in sales, which accounted 36.172 billon in 2008 . Novartis is one of the largest healthcare companies in the world and a leading giant among pharmaceutical companies. Novartis manufactures drugs such as clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec / Glivec), cyclosporin A (Neoral / Sandimmun), letrozole (Femara), methylphenidate (Ritalin), terbinafine (Lamisil), and others. Novartis owns Sandoz, a large manufacturer of generic drugs. The company formerly owned the Gerber Products Company, a major infant and baby products producer, but sold it to Nestlé on 1 September 2007.
Novartis is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
This text uses material from Wikipedia, licensed under CC BY-SA
